← Eichor
Study identifier: NCT06744985 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Comparison of RTS and MGAP Scores in Predicting Outcomes of Trauma Patients

Condition: Multiple Trauma/Injuries  ·  Sponsor: Al-Nahrain University

PhaseN/A
Planned participants200
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

The goal of this prospective cohort study is to compare the predictive accuracy of the Revised Trauma Score (RTS) and the MGAP score in determining clinical outcomes among multiple trauma patients hospitalized at a trauma center in Iraq. The main questions it aims to answer are: Which score, RTS or MGAP, provides a more accurate prediction of clinical outcomes, including mortality? Are there specific subgroups of trauma patients where one scoring system outperforms the other? Participants will: Be assessed using both the RTS and MGAP scores upon admission. Have their clinical outcomes, including mortality and other relevant indicators, monitored throughout their hospital stay.

This description comes directly from the study's public registry record.

Talk to the study team

Abdulillah R. Khamees  ·  +9647838571013  ·  allaabed987@ced.nahrainuniv.edu.iq

Always discuss trial participation with your own doctor first.

Locations (1)

College of Medicine - Al-Nahrain UniversityBaghdad, IraqRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06744985